Friday, July 26, 2019

// // Leave a Comment

Salk researchers identify two therapeutic targets for deadly lung cancer

The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called LKB1. Salk Institute researchers have now discovered precisely why inactive LKB1 results in cancer ...

from Google Alert - health https://ift.tt/2SODlI8
via IFTTT

0 comments:

Post a Comment